William Hoffman - 08 Jul 2022 Form 4 Insider Report for Inari Medical, Inc.

Role
President and CEO, Director
Signature
/s/ Angela Ahmad, attorney-in-fact for William Hoffman
Issuer symbol
N/A
Transactions as of
08 Jul 2022
Net transactions value
-$844,657
Form type
4
Filing time
12 Jul 2022, 17:52:00 UTC
Previous filing
08 Jul 2022
Next filing
20 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale $837,057 -11,137 -2.1% $75.16 524,274 08 Jul 2022 Direct F1, F2
transaction NARI Common Stock Sale $7,600 -100 -0.02% $76.00 524,174 08 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $75.00 to $75.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.